These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 9655715)

  • 1. Analysis of HLA-DPB1 polymorphisms in African-Americans with sarcoidosis.
    Maliarik MJ; Chen KM; Major ML; Sheffer RG; Popovich J; Rybicki BA; Iannuzzi MC
    Am J Respir Crit Care Med; 1998 Jul; 158(1):111-4. PubMed ID: 9655715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BTNL2 allele associations with chronic beryllium disease in HLA-DPB1*Glu69-negative individuals.
    Sato H; Spagnolo P; Silveira L; Welsh KI; du Bois RM; Newman LS; Maier LA
    Tissue Antigens; 2007 Dec; 70(6):480-6. PubMed ID: 17927685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Function associated transforming growth factor-beta gene polymorphism in chronic beryllium disease.
    Gaede KI; Amicosante M; Schürmann M; Fireman E; Saltini C; Müller-Quernheim J
    J Mol Med (Berl); 2005 May; 83(5):397-405. PubMed ID: 15750822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential susceptibilities to chronic beryllium disease contributed by different Glu69 HLA-DPB1 and -DPA1 alleles.
    Wang Z; White PS; Petrovic M; Tatum OL; Newman LS; Maier LA; Marrone BL
    J Immunol; 1999 Aug; 163(3):1647-53. PubMed ID: 10415070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic susceptibility to beryllium: a case-referent study of men and women of working age with sarcoidosis or other chronic lung disease.
    Cherry N; Beach J; Burstyn I; Parboosingh J; Schouchen J; Senthilselvan A; Svenson L; Tamminga J; Yiannakoulias N
    Occup Environ Med; 2015 Jan; 72(1):21-7. PubMed ID: 25305207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beryllium sensitivity is linked to HLA-DP genotype.
    Wang Z; Farris GM; Newman LS; Shou Y; Maier LA; Smith HN; Marrone BL
    Toxicology; 2001 Aug; 165(1):27-38. PubMed ID: 11551429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The association between HLA-DPB1Glu69 and chronic beryllium disease and beryllium sensitization.
    McCanlies EC; Ensey JS; Schuler CR; Kreiss K; Weston A
    Am J Ind Med; 2004 Aug; 46(2):95-103. PubMed ID: 15273960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA-DPB polymorphisms: Glu 69 association with sarcoidosis.
    Lympany PA; Petrek M; Southcott AM; Newman Taylor AJ; Welsh KI; du Bois RM
    Eur J Immunogenet; 1996 Oct; 23(5):353-9. PubMed ID: 8909942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sarcoidosis susceptibility and resistance HLA-DQB1 alleles in African Americans.
    Iannuzzi MC; Maliarik MJ; Poisson LM; Rybicki BA
    Am J Respir Crit Care Med; 2003 May; 167(9):1225-31. PubMed ID: 12615619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of MHC class II in susceptibility to beryllium sensitization and chronic beryllium disease.
    Maier LA; McGrath DS; Sato H; Lympany P; Welsh K; Du Bois R; Silveira L; Fontenot AP; Sawyer RT; Wilcox E; Newman LS
    J Immunol; 2003 Dec; 171(12):6910-8. PubMed ID: 14662898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The major histocompatibility complex gene region and sarcoidosis susceptibility in African Americans.
    Rybicki BA; Maliarik MJ; Poisson LM; Sheffer R; Chen KM; Major M; Chase GA; Iannuzzi MC
    Am J Respir Crit Care Med; 2003 Feb; 167(3):444-9. PubMed ID: 12554629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of HLA-DRB1 with Sarcoidosis Susceptibility and Progression in African Americans.
    Levin AM; Adrianto I; Datta I; Iannuzzi MC; Trudeau S; Li J; Drake WP; Montgomery CG; Rybicki BA
    Am J Respir Cell Mol Biol; 2015 Aug; 53(2):206-16. PubMed ID: 25506722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HLA-DPB1 glutamate 69: a genetic marker of beryllium disease.
    Richeldi L; Sorrentino R; Saltini C
    Science; 1993 Oct; 262(5131):242-4. PubMed ID: 8105536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DPB1*8501, a novel DPB1 variant in the US Black population.
    Rozemuller EH; van der Zwan AW; Voorter CE; Tilanus MG
    Tissue Antigens; 2000 Sep; 56(3):282-4. PubMed ID: 11034567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA-sequence determination of exon 2 of a novel HLA-DPB1 allele, HLA-DPB1*0403.
    Weston A; Ensey JS; Frye BL
    DNA Seq; 2005 Jun; 16(3):235-6. PubMed ID: 16147881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HLA-DPB1 and chronic beryllium disease: a HuGE review.
    McCanlies EC; Kreiss K; Andrew M; Weston A
    Am J Epidemiol; 2003 Mar; 157(5):388-98. PubMed ID: 12615603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of MHC encoded antigen-processing genes TAP1 and TAP2 polymorphisms in sarcoidosis.
    Foley PJ; Lympany PA; Puscinska E; Zielinski J; Welsh KI; du Bois RM
    Am J Respir Crit Care Med; 1999 Sep; 160(3):1009-14. PubMed ID: 10471632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DPB1*WA2 and DPB1*WA3--novel West African HLA DPB1 alleles closely related to the allele DPB1*0101 common in negroid populations.
    Meyer CG; Schnittger L; Gallin M; Erttmann KD; Brattig N; Begovich AB; Erlich HA; Horstmann RD
    Tissue Antigens; 1992 Mar; 39(3):144-6. PubMed ID: 1598688
    [No Abstract]   [Full Text] [Related]  

  • 19. HLA class II DPB1 and DRB1 polymorphisms associated with genetic susceptibility to beryllium toxicity.
    Rosenman KD; Rossman M; Hertzberg V; Reilly MJ; Rice C; Kanterakis E; Monos D
    Occup Environ Med; 2011 Jul; 68(7):487-93. PubMed ID: 21186201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of HLA class II DRB1, DPA1 and DPB1 polymorphism with genetic susceptibility to idiopathic dilated cardiomyopathy in Chinese Han nationality.
    Liu W; Li WM; Yang SS; Gao C; Li SJ; Li Y; Kong YH; Gan RT
    Autoimmunity; 2006 Sep; 39(6):461-7. PubMed ID: 17060025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.